Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Heparin Tolerability Study

NCT04490239 is registered in ClinicalTrials.gov with Joshua Sharp as lead sponsor.

NCT NCT04490239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04490239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Heparin Tolerability Study
Lead sponsor
Joshua Sharp
Phase
Phase 1
Overall status
Completed
Start date
October 9, 2020
Completion date
November 18, 2020
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19